Study protocol: baby-OSCAR trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial
<p><strong>BACKGROUND:</strong> The question of whether to treat patent ductus arteriosus (PDA) early or wait until symptoms appear remains high on the research agenda for neonatal medicine. Around 7000 extremely preterm babies under 29 weeks' gestation are born in...
Main Authors: | Gupta, S, Juszczak, E, Hardy, P, Subhedar, N, Wyllie, J, Kelsall, W, Sinha, S, Johnson, S, Roberts, T, Hutchison, E, Pepperell, J, Linsell, L, Bell, JL, Stanbury, K, Laube, M, Edwards, C, Field, D, ‘The Baby-OSCAR Collaborative Group’ |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
BMC
2021
|
Registos relacionados
-
Study protocol: baby-OSCAR trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial
Por: Samir Gupta, et al.
Publicado em: (2021-02-01) -
Trial of selective early treatment of patent ductus arteriosus with ibuprofen
Por: Gupta, S, et al.
Publicado em: (2024) -
Baby-OSCAR: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies—a statistical analysis plan for short-term outcomes
Por: Bell, JL, et al.
Publicado em: (2021) -
Spontaneous closure of patent ductus arteriosus in preterm babies after failed attempts at transcatheter device closure
Por: Ahmed Deniwar, et al.
Publicado em: (2022-01-01) -
Continued uncertainty regarding treatment of patent ductus arteriosus in premature infants and the role of clinical trials
Por: Juszczak, E, et al.
Publicado em: (2018)